Leiden – Start of the third  trial site in the Netherlands

Today,  Leiden University Medical Center  became officially an active trial site of the STOP-PKD Study.

 The team of Dr. H. Siebe Spijker cares for patients with a wide range of nephrological conditions, including those affected by autosomal dominant polycystic kidney disease (ADPKD).

 Interested patients can now make an appointment at the trial site in Leiden, Netherlands, to obtain detailed information about the trial and potential participation.

Phone:  details are coming soon

Email:   details are coming soon